Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 90 clinical trials
featured
A Phase 2b Study to Evaluate the Safety and Efficacy of Elagolix in Premenopausal Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids

A Phase 2b Study to Evaluate the Safety and Efficacy of Elagolix in Premenopausal Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids

  • 224 views
  • 23 Nov, 2020
  • 1 location
MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia

To compare the efficacy of Medroxyprogesterone Acetate with dydrogesterone in patients having endometrial hyperplasia (EH) without atypia.

  • 0 views
  • 25 Jan, 2021
  • 1 location
Anti-mullerian Hormone Levels in Healthy Females

The purpose of this study is to have a better understanding of the normal blood levels of AMH in females from 0-18 years of age and how the blood AMH levels correspond to a female's reproductive development.

  • 0 views
  • 25 Jan, 2021
Changes in Serum antim llerian Hormone Levels in Patients 3 and 12 Months After Endometrioma Sclerotherapy

Endometriosis affects 6-10% of women in childbearing age. It is a heterogeneous disease with three different forms: superficial endometriosis (peritoneal), ovarian endometrioma and deep pelvic endometriosis (subperitoneal). Surgical management of endometriomas is justified in cases of significant clinical symptoms (like pain), especially in cases of resistance to medical treatment. Currently, …

  • 0 views
  • 08 Mar, 2021
  • 3 locations
Low-Dose Danazol for the Treatment of Telomere Related Diseases

will take a sample of the marrow. All participants will have hormone levels checked. All child participants will see a pediatric endocrinologist. Children may need to have a hand

  • 57 views
  • 08 Apr, 2021
  • 1 location
Oophorectomy Estrogen Therapy and Cardiovascular Disease Risk in Young Women

Researchers are trying to assess the appropriate dose of estrogen for decreasing the risk of cardiovascular disease in women who have removal of their ovaries at a young age, before the age of 46 years.

  • 2 views
  • 28 Jan, 2021
  • 1 location
The Impact of Group Singing on Patients With Stroke and Their Personal Caregivers

The study will focus on the impact of communal singing on patients with stroke and their personal caregivers. Forty post-stroke patients will be randomly assigned to two groups: the first group of 20 stroke survivors and their caregivers (up to 40 total participants) will receive 6 months (approximately 24 sessions) …

  • 26 views
  • 14 Mar, 2021
  • 2 locations
Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma

To explore the treatment efficacy of megestrol acetate plus rosuvastatin in patients with early endometrial carcinoma (EEC) seeking for conservative treatment.

  • 0 views
  • 26 Jan, 2021
  • 1 location
Gastrografin for Treating Small Bowel Obstruction in Children

This is a multi-centre clustered open label clinical trial testing the effectiveness of adding Gastrografin to standard non-surgical management of small bowel obstruction. Gastrografin is a radiopaque contract agent that exhibits a mild laxative effective due to its high osmolarity and ability to pull water into the intestines and bowels …

  • 0 views
  • 28 Jan, 2021
  • 1 location
A Trial Study on Acupuncture Treatment of Poor Ovarian Response

The trial was completed by Shaanxi Provincial Hospital of Traditional Chinese Medicine and Northwest Women and Children's Hospital. Thirty-five patients with POR who underwent ART (Assisted Reproductive) treatment were observed in each center. Patients in the experimental group were given acupuncture treatment for 12 weeks prior to COH. If the …

  • 0 views
  • 22 Jan, 2021
  • 1 location